Skip to Content

79 Results Found

  • Opinion
  • Open Access
7 Citations
5,026 Views
6 Pages

Liver Transplantation and dd-cfDNA: A Small Solution for a Big Problem

  • Eleni Avramidou,
  • Stella Vasileiadou,
  • Nikolaos Antoniadis,
  • Georgios Katsanos and ,
  • Athanasios Kofinas,
  • Konstantina-Eleni Karakasi and
  • Georgios Tsoulfas
  • + 2 authors+ 0 author

20 February 2023

Dd-cfDNA is a novel biomarker with many diagnostic applications in various areas of medicine. In this review of the literature, we investigate its role in the diagnosis of many complications that occur in liver transplantations. In our review, we ret...

  • Article
  • Open Access
1 Citations
2,339 Views
13 Pages

21 June 2025

Background: Donor-derived cell-free DNA (dd-cfDNA) testing offers a non-invasive approach for monitoring allograft health in transplant recipients. However, its diagnostic performance and clinical utility remain insufficiently characterized across di...

(This article belongs to the Section Technologies and Resources for Genetics)
  • Communication
  • Open Access
466 Views
12 Pages

Early Donor-Derived Cell-Free DNA Kinetics After Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Preliminary Observational Study

  • Patryk Wawrzonkowski,
  • Kornelia Gajek,
  • Weronika Smulska,
  • Katarzyna Grabka and ,
  • Karolina Marek Bukowiec,
  • Magdalena Kuriata-Kordek,
  • Patryk Jerzak,
  • Adrian Domagalski,
  • Marek Ussowicz and
  • Mirosław Banasik
  • + 5 authors+ 0 author

17 August 2026

Donor-derived cell-free DNA (dd-cfDNA) is an emerging non-invasive biomarker of kidney allograft injury. Elevated dd-cfDNA has been associated with acute rejection, particularly antibody-mediated rejection; however, dd-cfDNA reflects graft-derived ti...

(This article belongs to the Special Issue Kidney Transplantation: Current Framework and New Perspectives)
  • Article
  • Open Access
13 Citations
2,731 Views
11 Pages

Donor-Derived Cell-Free DNA at 1 Month after Kidney Transplantation Relates to HLA Class II Eplet Mismatch Load

  • Elena González-López,
  • Javier Gonzalo Ocejo-Vinyals,
  • Mónica Renuncio-García,
  • Adriel Roa-Bautista and ,
  • David San Segundo Arribas,
  • Clara Escagedo,
  • María del Mar García-Saiz,
  • Rosalía Valero,
  • Pilar García-Berbel and
  • Emilio Rodrigo
  • + 6 authors+ 1 author

Kidney transplantation is the preferred therapeutic option for end-stage renal disease; however, the alloimmune response is still the leading cause of renal allograft failure. To better identify immunologic disparities in order to evaluate HLA compat...

(This article belongs to the Section Immunology and Immunotherapy)
  • Review
  • Open Access
46 Citations
10,320 Views
19 Pages

Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review

  • Adrian Martuszewski,
  • Patrycja Paluszkiewicz,
  • Magdalena Król,
  • Mirosław Banasik and
  • Marta Kepinska

7 January 2021

Kidney transplantation (KTx) is the best treatment method for end-stage kidney disease. KTx improves the patient’s quality of life and prolongs their survival time; however, not all patients benefit fully from the transplantation procedure. For...

(This article belongs to the Collection Novel Insights in Renal Transplantation)
  • Review
  • Open Access
9 Citations
8,117 Views
15 Pages

Donor-Derived Cell-Free DNA to Diagnose Graft Rejection Post-Transplant: Past, Present and Future

  • Naveen Kumar,
  • Rashmi Rana,
  • Devender Singh Rana,
  • Anurag Gupta and
  • Mohinder Pal Sachdeva

Donor-derived cell-free DNA (dd-cfDNA) is a non-invasive biomarker that is more sensitive and specific towards diagnosing any graft injury or rejection. Due to its applicability over all transplanted organs irrespective of age, sex, race, ethnicity,...

(This article belongs to the Special Issue State-of-the-Art of Engineering and Regenerating Organs to Improve Graft Survival after Transplantation)
  • Article
  • Open Access
6 Citations
2,489 Views
12 Pages

Early Monitoring of Donor-Derived Cell-Free DNA in Kidney Allograft Recipients Followed-Up for Two Years: Experience of One Center

  • Carmen Botella,
  • José Antonio Galián,
  • Víctor Jiménez-Coll,
  • Marina Fernández-González and ,
  • Francisco Morales,
  • Gloria Martínez-Gómez,
  • Rosana González-López,
  • María José Alegría,
  • María Rosa Moya and
  • Manuel Muro
  • + 9 authors+ 4 authors

16 November 2024

(1) Background: donor-derived circulating free DNA (dd-cfDNA), an innovative biomarker with great potential for the early identification and prevention of graft damage. (2) Methods: Samples were collected prospectively and the study was performed ret...

(This article belongs to the Special Issue Kidney Transplantation: What’s Hot and What’s New)
  • Article
  • Open Access
4 Citations
3,865 Views
14 Pages

Donor-Derived Cell-Free DNA as a Non-Invasive Biomarker for Graft Rejection in Kidney Transplant Recipients: A Prospective Study among the Indian Population

  • Naveen Kumar,
  • Archita Tandon,
  • Rashmi Rana,
  • Devinder Singh Rana and ,
  • Anil Kumar Bhalla,
  • Anurag Gupta,
  • Mohinder Pal Sachdeva,
  • Rohit Singh Huirem,
  • Kirti Chauhan and
  • Nirmal Kumar Ganguly
  • + 9 authors+ 4 authors

27 November 2023

Monitoring graft health and detecting graft rejection is crucial for the success of post-transplantation outcomes. In Western countries, the use of donor-derived cell-free DNA (dd-cfDNA) has gained widespread recognition as a diagnostic tool for kidn...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
4 Citations
3,229 Views
15 Pages

Whole-Exome Sequencing Followed by dPCR-Based Personalized Genetic Approach in Solid Organ Transplantation: A Study Protocol and Preliminary Results

  • Mirgul Bayanova,
  • Aidos Bolatov,
  • Dias Malik,
  • Aida Zhenissova and ,
  • Aizhan Abdikadirova,
  • Malika Sapargaliyeva,
  • Lyazzat Nazarova,
  • Gulzhan Myrzakhmetova,
  • Svetlana Novikova and
  • Yuriy Pya
  • + 6 authors+ 1 author

Genetic profiling and molecular biology methods have made it possible to study the etiology of the end-stage organ disease that led to transplantation, the genetic factors of compatibility and tolerance of the transplant, and the pharmacogenetics of...

(This article belongs to the Section Omics and High Throughput)
  • Article
  • Open Access
14 Citations
5,017 Views
20 Pages

Putative Clinical Potential of ERBB2 Amplification Assessment by ddPCR in FFPE-DNA and cfDNA of Gastroesophageal Adenocarcinoma Patients

  • Elisa Boldrin,
  • Marcodomenico Mazza,
  • Maria Assunta Piano,
  • Rita Alfieri and ,
  • Isabella Monia Montagner,
  • Giovanna Magni,
  • Maria Chiara Scaini,
  • Loretta Vassallo,
  • Antonio Rosato and
  • Matteo Curtarello
  • + 7 authors+ 2 authors

27 April 2022

Anti-HER2 monoclonal antibody trastuzumab improves the survival of those patients with advanced gastroesophageal adenocarcinoma (GEA) exhibiting HER2/ERBB2 overexpression/amplification. The current gold standard methods used to diagnose the HER2 stat...

(This article belongs to the Collection The Biomarkers for the Diagnosis and Prognosis in Cancer)
  • Protocol
  • Open Access
14 Citations
4,275 Views
9 Pages

KidneyCare Guided Immuno-Optimization in Renal Allografts: The KIRA Protocol

  • Jennifer N. Gray,
  • Theresa Wolf-Doty,
  • Nimisha Sulejmani,
  • Osama Gaber and ,
  • David Axelrod,
  • Basmah Abdalla and
  • Gabriel Danovitch
  • + 2 authors+ 0 author

30 September 2020

Immunosuppressant agents are essential in every transplant recipient’s care yet walking the fine line of over- or under-immunosuppression is a constant struggle for both patients and transplant providers alike. Optimization and personalization...

  • Editorial
  • Open Access
51 Citations
6,721 Views
10 Pages

The Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection and Injury Status

  • Charat Thongprayoon,
  • Pradeep Vaitla,
  • Iasmina M. Craici,
  • Napat Leeaphorn and ,
  • Panupong Hansrivijit,
  • Sohail Abdul Salim,
  • Tarun Bathini,
  • Franco H. Cabeza Rivera and
  • Wisit Cheungpasitporn
  • + 4 authors+ 0 author

Patient monitoring after kidney transplantation (KT) for early detection of allograft rejection remains key in preventing allograft loss. Serum creatinine has poor predictive value to detect ongoing active rejection as its increase is not sensitive,...

(This article belongs to the Section Nephrology & Urology)
  • Review
  • Open Access
11 Citations
5,192 Views
17 Pages

Heart Transplant Rejection: From the Endomyocardial Biopsy to Gene Expression Profiling

  • Anca Otilia Farcas,
  • Mihai Ciprian Stoica,
  • Ioana Maria Maier,
  • Adrian Cornel Maier and
  • Anca Ileana Sin

Heart transplant prolongs life for patients with end-stage heart failure but rejection remains a complication that reduces long-term survival. The aim is to provide a comprehensive overview of the current status in HT rejection. EMB is an invasive di...

(This article belongs to the Section Immunology and Immunotherapy)
  • Article
  • Open Access
10 Citations
3,881 Views
11 Pages

Detection of ESR1 Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma Patients

  • Dimitra Stergiopoulou,
  • Athina Markou,
  • Lydia Giannopoulou,
  • Paul Buderath and ,
  • Ioanna Balgkouranidou,
  • Nikolaos Xenidis,
  • Stylianos Kakolyris,
  • Sabine Kasimir-Bauer and
  • Evi Lianidou
  • + 4 authors+ 0 author

4 August 2022

ESR1 mutations have been recently associated with resistance to endocrine therapy in metastatic breast cancer and their detection has led to the development and current evaluation of novel, highly promising therapeutic strategies. In ovarian cancer t...

(This article belongs to the Special Issue Promising Biomarkers in Liquid Biopsy of Cancer)
  • Article
  • Open Access
5 Citations
4,452 Views
19 Pages

p53/TP53 Status Assessment in Gastroesophageal Adenocarcinoma

  • Elisa Boldrin,
  • Maria Assunta Piano,
  • Francesco Bernaudo,
  • Rita Alfieri and ,
  • Maria Raffaella Biasin,
  • Isabella Monia Montagner,
  • Alice Volpato,
  • Genny Mattara,
  • Francesco Lamacchia and
  • Matteo Curtarello
  • + 9 authors+ 4 authors

16 May 2023

Chromosomal instability (CIN) is very frequent in gastroesophageal adenocarcinoma (GEA) and it is characterized by TP53 deletions/mutations resulting in p53 nuclear accumulation, as revealed by immunohistochemistry (IHC), which considers the cases wi...

(This article belongs to the Special Issue Cell-Free DNA as Prognostic and Predictive Biomarker in Solid Cancers)
  • Article
  • Open Access
10 Citations
3,511 Views
13 Pages

A Case–Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection

  • Marina Bortul,
  • Fabiola Giudici,
  • Domenico Tierno,
  • Daniele Generali and ,
  • Serena Scomersi,
  • Gabriele Grassi,
  • Cristina Bottin,
  • Maria Rosa Cappelletti,
  • Fabrizio Zanconati and
  • Bruna Scaggiante
  • + 5 authors+ 0 author

Background: In Western countries, breast cancer (BC) is the most common cancer in women. Early detection has a positive impact on survival, quality of life, and public health costs. Mammography screening programs have increased early detection rates,...

(This article belongs to the Special Issue Circulating Cell-Free Nucleic Acids and Cancers: 2nd Edition)
  • Article
  • Open Access
4 Citations
2,248 Views
16 Pages

Integrated Analysis of Cell-Free DNA and Novel Protein Biomarkers for Stratification and Therapy Monitoring in Stage IV Pancreatic Cancer: A Preliminary Study

  • Saskia Hussung,
  • Maria E. Hess,
  • Elham Bavafaye Haghighi,
  • Uwe A. Wittel and ,
  • Melanie Boerries and
  • Ralph M. Fritsch
  • + 1 author+ 0 author

Background: Given the poor prognosis of metastatic pancreatic adenocarcinoma (mPDAC), closer disease monitoring through liquid biopsy, most frequently based on serial measurements of cell-free mutated KRAS (KRASmut cfDNA), has become a highly active...

(This article belongs to the Section Clinical Diagnosis and Prognosis)
  • Article
  • Open Access
6 Citations
3,107 Views
17 Pages

Plasma Sequencing for Patients with GIST—Limitations and Opportunities in an Academic Setting

  • Johanna Falkenhorst,
  • Susanne Grunewald,
  • Dawid Krzeciesa,
  • Thomas Herold and ,
  • Julia Ketzer,
  • Miriam Christoff,
  • Rainer Hamacher,
  • Karina Kostbade,
  • Jürgen Treckmann and
  • Sebastian Bauer
  • + 12 authors+ 7 authors

9 November 2022

Circulating tumor DNA (ctDNA) from circulating free DNA (cfDNA) in GIST is of interest for the detection of heterogeneous resistance mutations and treatment monitoring. However, methodologies for use in a local setting are not standardized and are er...

  • Review
  • Open Access
21 Citations
5,545 Views
16 Pages

Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia

  • Irene Della Starza,
  • Lucia Anna De Novi,
  • Loredana Elia,
  • Vittorio Bellomarino and ,
  • Marco Beldinanzi,
  • Roberta Soscia,
  • Deborah Cardinali,
  • Sabina Chiaretti,
  • Anna Guarini and
  • Robin Foà
  • + 5 authors+ 0 author

6 January 2023

Minimal/measurable residual disease (MRD) evaluation has resulted in a fundamental instrument to guide patient management in acute lymphoblastic leukemia (ALL). From a methodological standpoint, MRD is defined as any approach aimed at detecting and p...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
9 Citations
2,942 Views
9 Pages

Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study

  • Bilgin Osmanodja,
  • Aylin Akifova,
  • Michael Oellerich,
  • Julia Beck and ,
  • Kirsten Bornemann-Kolatzki,
  • Ekkehard Schütz and
  • Klemens Budde
  • + 2 authors+ 0 author

22 March 2023

Donor-derived cell-free DNA (dd-cfDNA) is used as a biomarker for detection of antibody-mediated rejection (ABMR) and other forms of graft injury. Another potential indication is guidance of immunosuppressive therapy when no therapeutic drug monitori...

(This article belongs to the Section Nephrology & Urology)
  • Article
  • Open Access
3 Citations
1,647 Views
12 Pages

Donor-Derived Cell-Free DNA Versus Left Ventricular Longitudinal Strain and Strain-Derived Myocardial Work Indices for Identification of Heart Transplant Injury

  • Timea Teszak,
  • Timea Barcziova,
  • Csaba Bödör,
  • Lajos Hegyi and ,
  • Luca Levay,
  • Beata Nagy,
  • Attila Fintha,
  • Adam Szijarto,
  • Attila Kovacs and
  • Balazs Sax
  • + 6 authors+ 1 author

Background/Objectives: Donor-derived cell-free DNA (dd-cfDNA) is a marker of graft injury that increases in acute rejection and has excellent negative predictive value. Left ventricular global longitudinal strain (LVGLS) and strain-derived myocardial...

(This article belongs to the Special Issue Advances in Biomarker Discovery for Cardiovascular Disease)
  • Article
  • Open Access
  • Best Paper Award
203 Citations
19,020 Views
17 Pages

Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR

  • Tara K. Sigdel,
  • Felipe Acosta Archila,
  • Tudor Constantin,
  • Sarah A. Prins and ,
  • Juliane Liberto,
  • Izabella Damm,
  • Parhom Towfighi,
  • Samantha Navarro,
  • Eser Kirkizlar and
  • Minnie M. Sarwal
  • + 14 authors+ 9 authors

23 December 2018

Standard noninvasive methods for detecting renal allograft rejection and injury have poor sensitivity and specificity. Plasma donor-derived cell-free DNA (dd-cfDNA) has been reported to accurately detect allograft rejection and injury in transplant r...

(This article belongs to the Section Nephrology & Urology)
  • Review
  • Open Access
3 Citations
1,509 Views
13 Pages

Diagnostic and Prognostic Value of Donor-Derived Cell-Free DNA in Acute Rejection After Kidney Transplantation: A Narrative Review

  • Stella Vasileiadou,
  • Nikolaos Antoniadis,
  • Asimina Fylaktou,
  • Stavros Neiros and ,
  • Filippos F. Karageorgos,
  • Maria Stangou,
  • Emmanouil Sinakos,
  • Serafeim-Chrysovalantis Kotoulas,
  • Eleni Massa and
  • Georgios Tsoulfas
  • + 6 authors+ 1 author

26 February 2026

Background: Kidney transplantation is the optimal treatment for end-stage renal disease; however, acute rejection remains a major determinant of long-term graft dysfunction and failure. Donor-derived cell-free DNA (dd-cfDNA) has emerged as a minimall...

(This article belongs to the Special Issue Current Issues in Kidney Diseases Diagnosis and Management 2025)
  • Article
  • Open Access
5 Citations
2,463 Views
11 Pages

Kidney Allograft Monitoring by Combining Donor-Derived Cell-Free DNA and Molecular Gene Expression: A Clinical Management Perspective

  • Asim Rizvi,
  • Sara Faiz,
  • Parin H. Thakkar,
  • Syed Hussain and ,
  • Ann N. Gamilla-Crudo,
  • Michael Kueht and
  • Muhammad A. Mujtaba
  • + 2 authors+ 0 author

29 July 2023

Donor-derived cell-free DNA (dd-cfDNA) may safely assess kidney allograft rejection. Molecular Microscope (MMDx®) gene expression may offer increased precision to histology. This single-center retrospective study monitored kidney transplant recip...

(This article belongs to the Section Personalized Therapy in Clinical Medicine)
  • Review
  • Open Access
15 Citations
3,293 Views
13 Pages

All That Glitters in cfDNA Analysis Is Not Gold or Its Utility Is Completely Established Due to Graft Damage: A Critical Review in the Field of Transplantation

  • Victor Jiménez-Coll,
  • Jaouad El kaaoui El band,
  • Santiago Llorente,
  • Rosana González-López and ,
  • Marina Fernández-González,
  • Helios Martínez-Banaclocha,
  • José Antonio Galián,
  • Carmen Botella,
  • María Rosa Moya-Quiles and
  • Manuel Muro
  • + 7 authors+ 2 authors

In kidney transplantation, a biopsy is currently the gold standard for monitoring the transplanted organ. However, this is far from an ideal screening method given its invasive nature and the discomfort it can cause the patient. Large-scale studies i...

(This article belongs to the Special Issue Advances in the Diagnosis and Management of Kidney Diseases)
  • Article
  • Open Access
4 Citations
4,118 Views
11 Pages

Integrating Donor Derived Cell-Free DNA Fraction and Absolute Quantification for Enhanced Rejection Diagnosis in Kidney Transplant Recipients

  • Weijian Nie,
  • Yan Wang,
  • Qian Fu,
  • Chenglin Wu and ,
  • Ronghai Deng,
  • Xiaolin Yu,
  • Caiguo Ye,
  • Xiangjun Liu,
  • Bowen Xu and
  • Changxi Wang
  • + 9 authors+ 4 authors

Background: This study aimed to assess the diagnostic accuracy of combining donor-derived cell-free DNA (dd-cfDNA) fraction and absolute quantification in detecting kidney allograft rejection. Methods: A prospective study was conducted from December...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
2 Citations
1,811 Views
13 Pages

Exploring Net Immunosuppressive Status with Torque Teno Virus Viral Load in Kidney Transplant Recipients with High Molecular Injury

  • Emilio Rodrigo,
  • Elena González-López,
  • Javier Gonzalo Ocejo-Vinyals,
  • Enrique Pasache and ,
  • Cristina García-Majado,
  • Covadonga López del Moral,
  • Ana García-Santiago,
  • Adalberto Benito-Hernández,
  • María Victoria Francia and
  • Juan Carlos Ruiz
  • + 5 authors+ 0 author

1 April 2025

Background/Objectives: New monitoring methods are being developed to improve the kidney transplant outcome. Among them, the measurement of Torque Teno virus load (TTV load) has been associated with the overall immunosuppressive status and the percent...

(This article belongs to the Special Issue Advances in Kidney Transplantation)
  • Review
  • Open Access
11 Citations
4,305 Views
4 Pages

Since its first detection in 1948, donor-derived cell-free DNA (dd-cfDNA) has been employed for a myriad of indications in various medical specialties. It has had a far-reaching impact in solid organ transplantation, with the most widespread utilizat...

(This article belongs to the Section Urology & Nephrology)
  • Article
  • Open Access
1 Citations
1,817 Views
15 Pages

LINE-1 266/97 and ALU 260/111 Copy Number Ratios in Circulating Cell-Free DNA in Plasma as Potential Biomarkers for the Detection of Prostate Cancer: A Pilot Case-Control Study

  • Domenico Tierno,
  • Nicola Pavan,
  • Fabiola Giudici,
  • Gabriele Grassi and ,
  • Eleonora Valeri,
  • Fabrizio Zanconati,
  • Fabio Traunero,
  • Giovanni Liguori and
  • Bruna Scaggiante
  • + 4 authors+ 0 author

11 September 2025

Prostate cancer (PCa) is the second most common cancer and the fourth leading cause of cancer death in men worldwide. PSA screening for PCa diagnosis is not disease-specific; the discovery of novel and efficient biomarkers is therefore recommended. T...

(This article belongs to the Special Issue Circulating Cell-Free Nucleic Acids and Cancers: 3rd Edition)
  • Review
  • Open Access
21 Citations
4,586 Views
14 Pages

Current Trends in Cell-Free DNA Applications. Scoping Review of Clinical Trials

  • Robert Stawski,
  • Emilia Stec-Martyna,
  • Adam Chmielecki,
  • Dariusz Nowak and
  • Ewelina Perdas

13 September 2021

We aimed to summarize the current knowledge about the trends in cfDNA application based on the analysis of clinical trials registered until April 2021. International Clinical Trials Registry Platform (ICTRP) and Clinicaltrials.gov were searched with...

(This article belongs to the Section Medical Biology)
  • Review
  • Open Access
11 Citations
4,622 Views
16 Pages

Cell-Free DNA as a Surveillance Tool for Hepatocellular Carcinoma Patients after Liver Transplant

  • Joao Manzi,
  • Camilla O. Hoff,
  • Raphaella Ferreira,
  • Renata Glehn-Ponsirenas and ,
  • Gennaro Selvaggi,
  • Akin Tekin,
  • Christopher B. O’Brien,
  • Lynn Feun,
  • Rodrigo Vianna and
  • Phillipe Abreu
  • + 5 authors+ 0 author

13 June 2023

The liver is the world’s sixth most common primary tumor site, responsible for approximately 5% of all cancers and over 8% of cancer-related deaths. Hepatocellular carcinoma (HCC) is the predominant type of liver cancer, accounting for approxim...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
2 Citations
4,308 Views
12 Pages

From Pediatric to Adult Brain Cancer: Exploring Histone H3 Mutations in Australian Brain Cancer Patients

  • Benedicte Grebstad Tune,
  • Heena Sareen,
  • Branka Powter,
  • Smadar Kahana-Edwin and ,
  • Adam Cooper,
  • Eng-Siew Koh,
  • Cheok S. Lee,
  • Joseph W. Po,
  • Geoff McCowage and
  • Yafeng Ma
  • + 16 authors+ 11 authors

Genetic histone variants have been implicated in cancer development and progression. Mutations affecting the histone 3 (H3) family, H3.1 (encoded by HIST1H3B and HIST1H3C) and H3.3 (encoded by H3F3A), are mainly associated with pediatric brain cancer...

(This article belongs to the Special Issue Gliomas: Signaling Pathways, Molecular Mechanisms and Therapeutic Approaches)
  • Review
  • Open Access
9 Citations
4,961 Views
16 Pages

Genomic and Biomarker Innovations in Predicting Kidney Transplant Rejection

  • Rachana Punukollu,
  • Sandesh Parajuli,
  • Harshad Chaudhari and
  • Girish Mour

22 May 2025

Currently, approximately 90,000 patients are on the kidney transplant waitlist in the United States, including 10,000 individuals awaiting re-transplantation due to prior graft failure. Allograft rejection remains a leading cause of kidney transplant...

(This article belongs to the Section Nephrology & Urology)
  • Review
  • Open Access
11 Citations
3,941 Views
6 Pages

Monitoring kidney transplant recipients for evidence of allograft rejection is essential to lower the risk of graft loss. The traditional method relies on serial checks in serum creatinine with a biopsy of the allograft if dysfunction is suspected. T...

(This article belongs to the Section Urology & Nephrology)
  • Review
  • Open Access
37 Citations
4,624 Views
13 Pages

8 February 2023

The cell-free DNA (cfDNA) levels are known to increase in biological fluids in various pathological conditions. However, the data on circulating cfDNA in severe psychiatric disorders, including schizophrenia, bipolar disorder (BD), and depressive dis...

(This article belongs to the Section Molecular Genetics and Genomics)
  • Article
  • Open Access
94 Citations
12,159 Views
14 Pages

Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol

  • Laure Sorber,
  • Karen Zwaenepoel,
  • Julie Jacobs,
  • Koen De Winne and ,
  • Sofie Goethals,
  • Pablo Reclusa,
  • Kaat Van Casteren,
  • Elien Augustus,
  • Filip Lardon and
  • Patrick Pauwels
  • + 9 authors+ 4 authors

30 March 2019

The combined analysis of circulating cell-free (tumor) DNA (cfDNA/ctDNA) and circulating cell-free (tumor) RNA (cfRNA/ctRNA) shows great promise in determining the molecular profile of cancer patients. Optimization of the workflow is necessary to ach...

(This article belongs to the Special Issue Liquid Biopsy for Cancer)
  • Article
  • Open Access
44 Citations
7,279 Views
18 Pages

Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer

  • Md Ismail Hosen,
  • Nathalie Forey,
  • Geoffroy Durand,
  • Catherine Voegele and ,
  • Selin Bilici,
  • Patrice Hodonou Avogbe,
  • Tiffany Myriam Delhomme,
  • Matthieu Foll,
  • Arnaud Manel and
  • Maria Zvereva
  • + 21 authors+ 16 authors

27 November 2020

Somatic mutations in the telomerase reverse transcriptase (TERT) promoter regions are frequent events in urothelial cancer (UC) and their detection in urine (supernatant cell-free DNA or DNA from exfoliated cells) could serve as putative non-invasive...

(This article belongs to the Special Issue Non-Invasive Early Detection of Cancers)
  • Review
  • Open Access
11 Citations
5,519 Views
26 Pages

Non-Invasive Biomarkers for Early Diagnosis of Kidney Allograft Dysfunction: Current and Future Applications in the Era of Precision Medicine

  • Christina Lazarou,
  • Eleni Moysidou,
  • Michalis Christodoulou,
  • Georgios Lioulios and ,
  • Erasmia Sampani,
  • Chrysostomos Dimitriadis,
  • Asimina Fylaktou and
  • Maria Stangou
  • + 3 authors+ 0 author

4 February 2025

Kidney transplantation stands as the preferred treatment for end-stage kidney disease, significantly improving both the quality and longevity of life compared to dialysis. In recent years, the survival rates for patients and grafts have markedly incr...

(This article belongs to the Section Urology & Nephrology)
  • Article
  • Open Access
10 Citations
4,814 Views
14 Pages

MSI Analysis in Solid and Liquid Biopsies of Gastroesophageal Adenocarcinoma Patients: A Molecular Approach

  • Elisa Boldrin,
  • Maria Assunta Piano,
  • Rita Alfieri,
  • Marcodomenico Mazza and ,
  • Loretta Vassallo,
  • Antonio Scapinello,
  • Pierluigi Pilati and
  • Matteo Curtarello
  • + 3 authors+ 0 author

Gastroesophageal adenocarcinoma (GEA) patients with the microsatellite instability (MSI) subtype emerged as optimal candidates for immunotherapy. To date, immunohistochemistry (IHC) is the gold standard for MSI assessment in formalin-fixed paraffin-e...

(This article belongs to the Special Issue Liquid Biopsies in Cancer Diagnosis, Monitoring and Prognosis)
  • Article
  • Open Access
23 Citations
5,080 Views
16 Pages

Detection of Somatic Mutations with ddPCR from Liquid Biopsy of Colorectal Cancer Patients

  • Uršula Prosenc Zmrzljak,
  • Rok Košir,
  • Zoran Krivokapić,
  • Dragica Radojković and
  • Aleksandra Nikolić

19 February 2021

Liquid biopsy and cell-free DNA (cfDNA) show great promise in cancer diagnostics. In this study, we designed a custom droplet digital PCR (ddPCR) assay for the quantification and quality control of cfDNA isolated from serum. The assay was validated o...

(This article belongs to the Special Issue Colorectal Cancer Genetics, Epigenetics, and Emerging Therapies)
  • Article
  • Open Access
18 Citations
4,764 Views
11 Pages

MYD88L265P Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation

  • Martina Ferrante,
  • Daniela Furlan,
  • Silvia Zibellini,
  • Michela Borriero and ,
  • Chiara Candido,
  • Nora Sahnane,
  • Silvia Uccella,
  • Elisa Genuardi,
  • Beatrice Alessandria and
  • Daniela Drandi
  • + 16 authors+ 11 authors

In IgM monoclonal gammopathies MYD88L265P is a prognostic and predictive biomarker of therapy response. MYD88L265P detection is mainly performed by allele-specific quantitative PCR (ASqPCR), however recently, droplet digital PCR (ddPCR) has been prov...

(This article belongs to the Special Issue Advances in Hematology Laboratory)
  • Article
  • Open Access
13 Citations
4,436 Views
18 Pages

The Challenge to Stabilize, Extract and Analyze Urinary Cell-Free DNA (ucfDNA) during Clinical Routine

  • Ivonne Nel,
  • Carolin Münch,
  • Saikal Shamkeeva,
  • Mitja L. Heinemann and ,
  • Berend Isermann and
  • Bahriye Aktas
  • + 1 author+ 0 author

14 December 2023

Background: The “Liquid Biopsy” has become a powerful tool for cancer research during the last decade. Circulating cell-free DNA (cfDNA) that originates from tumors has emerged as one of the most promising analytes. In contrast to plasma-...

(This article belongs to the Topic Biomarker Development and Application)
  • Article
  • Open Access
55 Citations
4,456 Views
12 Pages

Bile-Based Cell-Free DNA Analysis Is a Reliable Diagnostic Tool in Pancreatobiliary Cancer

  • Caroline Driescher,
  • Katharina Fuchs,
  • Lena Haeberle,
  • Wolfgang Goering and ,
  • Lisa Frohn,
  • Friederike V. Opitz,
  • Dieter Haeussinger,
  • Wolfram Trudo Knoefel,
  • Verena Keitel and
  • Irene Esposito
  • + 5 authors+ 0 author

25 December 2020

Currently available serum biomarkers for pancreatobiliary cancers lack sensitivity and specificity and ultimate diagnosis still requires invasive procedures for histological confirmation. The detection of tumor-specific genetic aberrations with utili...

  • Article
  • Open Access
11 Citations
4,052 Views
15 Pages

Longitudinal Study of Circulating Biomarkers in Patients with Resectable Pancreatic Ductal Adenocarcinoma

  • Pablo J. Dopico,
  • Minh-Chau N. Le,
  • Benjamin Burgess,
  • Zhijie Yang and ,
  • Yu Zhao,
  • Youxiang Wang,
  • Thomas J. George and
  • Z. Hugh Fan
  • + 3 authors+ 0 author

30 March 2022

While patients with resectable pancreatic ductal adenocarcinoma (PDAC) show improved survival compared to their non-resectable counterparts, survival remains low owing to occult metastatic disease and treatment resistance. Liquid biopsy based on circ...

(This article belongs to the Special Issue Lab on a Chip for High-Throughput Drug Screening)
  • Article
  • Open Access
19 Citations
4,519 Views
20 Pages

Simultaneous Ultra-Sensitive Detection of Structural and Single Nucleotide Variants Using Multiplex Droplet Digital PCR in Liquid Biopsies from Children with Medulloblastoma

  • Cecilia Arthur,
  • Cecilia Jylhä,
  • Teresita Díaz de Ståhl,
  • Alia Shamikh and ,
  • Johanna Sandgren,
  • Richard Rosenquist,
  • Magnus Nordenskjöld,
  • Arja Harila,
  • Gisela Barbany and
  • Emma Tham
  • + 6 authors+ 1 author

25 March 2023

Medulloblastoma is a malignant embryonal tumor of the central nervous system (CNS) that mainly affects infants and children. Prognosis is highly variable, and molecular biomarkers for measurable residual disease (MRD) detection are lacking. Analysis...

(This article belongs to the Special Issue Liquid Biopsy: Current Status and Future Perspectives)
  • Article
  • Open Access
679 Views
15 Pages

Development and Broad Application of a Double Drop-Off ddPCR Assay for Simultaneous Detection of Four FGFR3 Mutations in Tissue and Liquid Biopsy Samples

  • Eleni Thanou,
  • Nikos Gavalas,
  • Eleni Kabrani,
  • Foteini Grigoriou and ,
  • Anna Konstantinou,
  • Vasiliki Malamatini,
  • Christina Chourdaki Peristeri,
  • Evi Lianidou,
  • Aristotelis Bamias and
  • Athina Markou
  • + 5 authors+ 0 author

14 August 2026

Background: Fibroblast Growth Factor Receptor 3 (FGFR3) mutations are common and clinically relevant alterations in bladder cancer, with implications for diagnosis, monitoring, and patient selection for targeted therapies. Tissue-based testing is oft...

(This article belongs to the Section Cancer Biomarkers)
  • Article
  • Open Access
10 Citations
3,535 Views
22 Pages

The Impact of Liquid Biopsy in Advanced Ovarian Cancer Care

  • Antoni Llueca,
  • Sarai Canete-Mota,
  • Anna Jaureguí,
  • Manuela Barneo and ,
  • Maria Victoria Ibañez,
  • Alexander Neef,
  • Enrique Ochoa,
  • Sarai Tomas-Perez,
  • Josep Mari-Alexandre and
  • Maria Llueca
  • + 11 authors+ 6 authors

26 August 2024

Introduction: Ovarian cancer is the third most common gynaecological cancer and has a very high mortality rate. The cornerstone of treatment is complete debulking surgery plus chemotherapy. Even with treatment, 80% of patients have a recurrence. Circ...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
290 Views
20 Pages

Comparative Detection of IDH1 R132H and TERT Promoter Mutations in Plasma and Cerebrospinal Fluid of Patients with Glioma Using Targeted Droplet Digital PCR

  • Mark Jain,
  • Tagir Rahmatullin,
  • Ivan Alexeev,
  • Ariadna Gomershtat and ,
  • Margarita Gundobina,
  • Larisa Samokhodskaya and
  • Andrey Zuev
  • + 2 authors+ 0 author

14 October 2026

Background/Objectives: Molecular profiling is essential for glioma classification, but in some cases tissue sampling may be limited, whereas reported detectability of cell-free tumor DNA (cftDNA) in plasma and cerebrospinal fluid (CSF) varies conside...

(This article belongs to the Special Issue Utilization of Liquid Biopsy in Cancer Diagnosis and Management 2025–2026)
  • Article
  • Open Access
56 Citations
8,957 Views
13 Pages

Pre-Analytical Evaluation of Streck Cell-Free DNA Blood Collection Tubes for Liquid Profiling in Oncology

  • Inga Medina Diaz,
  • Annette Nocon,
  • Stefanie A. E. Held,
  • Makbule Kobilay and ,
  • Dirk Skowasch,
  • Abel J. Bronkhorst,
  • Vida Ungerer,
  • Johannes Fredebohm,
  • Frank Diehl and
  • Frank Holtrup
  • + 6 authors+ 1 author

Excellent pre-analytical stability is an essential precondition for reliable molecular profiling of circulating tumor DNA (ctDNA) in oncological diagnostics. Therefore, in vitro degradation of ctDNA and the additional release of contaminating genomic...

(This article belongs to the Special Issue Cell-Free Nucleic Acids—New Insights into Physico-Chemical Properties, Analytical Considerations, and Clinical Applications)
  • Article
  • Open Access
8 Citations
2,902 Views
10 Pages

Low Impact of Clonal Hematopoiesis on the Determination of RAS Mutations by Cell-Free DNA Testing in Routine Clinical Diagnostics

  • Cristin Roma,
  • Alessandra Sacco,
  • Laura Forgione,
  • Riziero Esposito Abate and ,
  • Matilde Lambiase,
  • Serena Dotolo,
  • Monica Rosaria Maiello,
  • Daniela Frezzetti,
  • Guglielmo Nasti and
  • Nicola Normanno
  • + 7 authors+ 2 authors

Targeted sequencing of circulating cell-free DNA (cfDNA) is used in routine clinical diagnostics for the identification of predictive biomarkers in cancer patients in an advanced stage. The presence of KRAS mutations associated with clonal hematopoie...

(This article belongs to the Special Issue Cell-Free Nucleic Acids—New Insights into Physico-Chemical Properties, Analytical Considerations, and Clinical Applications)

of 2